share_log

Psychedelic Stock Gainers And Losers From October 17, 2022

Psychedelic Stock Gainers And Losers From October 17, 2022

迷幻股票涨跌者自2022年10月17日起
Benzinga Real-time News ·  2022/10/17 16:56

GAINERS:

赢家：

  • Biomind Labs (OTC:BMNDF) shares closed up 38.18% at $1.52
  • Numinus Wellness (OTC:NUMIF) shares closed up 5.42% at $0.20
  • Compass Pathways (NASDAQ:CMPS) shares closed up 2.43% at $9.69
  • Seelos Therapeutics (NASDAQ:SEEL) shares closed up 2.40% at $0.93
  • Biomind实验室(场外交易代码：BMNDF)股价收盘上涨38.18%，至1.52美元
  • 努米诺斯健康(场外交易代码：NUMIF)股价收盘上涨5.42%，至0.2美元。
  • 指南针路径纳斯达克：CMPS股价收盘上涨2.43%，至9.69美元
  • Seelos治疗公司(纳斯达克股票代码：SEEL)股价收盘上涨2.40%，至0.93美元

LOSERS:

失败者：

  • Revive Therapeutics (OTC:RVVTF) shares closed down 10.63% at $0.20
  • Allied (OTC:ALID) shares closed down 3.90% at $0.48
  • Cybin (AMEX:CYBN) shares closed down 3.60% at $0.55
  • ATAI Life Sciences (NASDAQ:ATAI) shares closed down 2.33% at $2.94
  • Mind Medicine (NASDAQ:MNMD) shares closed down 0.69% at $2.87
  • GH Research (NASDAQ:GHRS) shares closed down 0.00% at $11.74
  • 复兴治疗学(场外交易：RVVTF)股价收盘下跌10.63%，至0.20美元
  • 盟军(场外交易代码：Alid)股价收盘下跌3.90%，至0.48美元
  • Cybin(美国证券交易所代码：CYBN)股价收盘下跌3.60%，至0.55美元。
  • 阿泰生命科学(纳斯达克：ATAI)股价收盘下跌2.33%，至2.94美元
  • 精神医学纳斯达克股价收盘下跌0.69%，至2.87美元
  • GH研究(纳斯达克：GHRS)股价收盘下跌0.00%，至11.74美元

This article was generated by Benzinga's automated content engine and reviewed by an editor.

本文由Benzinga的自动内容引擎生成，并由编辑审阅。

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发